Male Infertility and IVF: When IVF Helps and What It Does Not Solve

Medically reviewed on 12 August 2026 - Dr. Senai Aksoy
Couple discussing fertility options calmly

Key Takeaways

Male infertility contributes to a large share of fertility problems and is not solved by IVF in the same way for every couple. The right treatment depends on the underlying cause, whether that is a sperm production problem, blockage, hormonal issue, varicocele, or genetic factor. IVF and ICSI can help many couples, but they work best after a proper male-factor evaluation.

Key evidence: EAU Guidelines — Male infertility AUA/ASRM — Diagnosis and Treatment of Infertility in Men (2020, amended 2024)

Male Infertility and IVF

When a couple is struggling to conceive, male-factor infertility is often reduced to one phrase: “the sperm count is low.” That shortcut misses important differences. The problem may involve sperm production, transport, ejaculation, hormones, genetics, or more than one factor at the same time.

IVF can help in many of these situations. It is not, however, a cure for every male infertility diagnosis. The useful question is not simply “Do we need IVF?” It is “What is causing the problem, and which part of it can IVF or ICSI actually bypass?”

How male infertility is usually classified

Male-factor infertility is often grouped into three broad levels:

This classification is practical, not just academic. A hormonal disorder may need medical treatment, an obstruction may be surgically correctable, and a genetic finding may change counselling and inheritance-risk discussions. IVF is only one possible part of that pathway. The EAU male-infertility guideline and the AUA/ASRM guideline support cause-specific evaluation rather than an automatic move to assisted reproduction.

What the male infertility workup should include

A proper evaluation starts with a semen analysis. If that first result is normal, one test is generally enough; if it is abnormal, the EAU guideline advises repeating it, because sperm parameters vary from one sample to the next. Depending on the case, clinicians may also review:

This step is important not only for choosing treatment, but also for avoiding missed diagnoses such as hypogonadotropic hypogonadism, congenital absence of the vas deferens, or Y-chromosome microdeletions.

When IVF helps in male infertility

IVF becomes relevant when natural conception or simpler treatment is unlikely to work, or when time matters. Its role varies by problem.

Low sperm count or poor motility

When sperm concentration or motility is very poor, conventional fertilization becomes less predictable. IVF with ICSI is often used so that one selected sperm can be injected directly into each mature egg. ICSI answers a specific problem rather than serving as a default setting for every cycle: where there is no male factor at all, the 2026 ASRM committee opinion advises against routine ICSI, because it has not been shown to improve live birth rates in that setting.

Abnormal sperm morphology

Abnormal shape alone does not automatically mean that ICSI is required. Morphology is interpreted alongside count, motility, the rest of the evaluation, and the couple’s history. No guideline statement singles out mild morphology abnormality as a standing indication for ICSI; that reading follows from the cause-specific approach the AUA/ASRM guideline takes as a whole, and it is how we apply it in practice.

Obstructive azoospermia

If sperm production is intact but blocked from reaching the ejaculate, sperm can usually be retrieved surgically and used with IVF-ICSI. The EAU and AUA/ASRM guidelines treat retrieval as an established option here. Repairing the obstruction itself is sometimes an alternative worth discussing, which is one reason the cause is worth identifying before booking a cycle.

Non-obstructive azoospermia

These are more difficult cases because sperm production itself is impaired. Some men still have focal sperm production in the testes, and techniques such as micro-TESE may allow retrieval for ICSI. Sperm are not found in every attempt, and the Y-chromosome result changes the picture sharply.

Where a complete deletion involves the AZFa or AZFb region, the EAU guideline recommends against attempting surgical sperm retrieval. Those deletions go with a Sertoli-cell-only pattern or arrested sperm production, so sperm are not expected to be found and the operation cannot succeed. A deletion limited to the AZFc region is a different situation: in that group the same guideline reports sperm retrieved in roughly 50–75% of men.

This is the clearest example of why Y-chromosome testing belongs before surgery rather than after it. The result does not just adjust the odds — in one case it takes the operation off the table entirely.

IVF is not the treatment for every male problem

This is the point that often gets lost. IVF does not correct the underlying male condition. It bypasses some of its consequences. That difference matters.

For example:

IVF is therefore best viewed as one part of the treatment pathway, not the entire diagnosis.

What determines success

Even in male-factor infertility, success is not determined by sperm alone. Outcomes still depend heavily on:

That is why two couples with similar semen results can receive different recommendations—and why a semen analysis should not be read as a prognosis by itself. The AUA/ASRM guideline emphasises that evaluation and treatment should consider both partners.

Dr. Aksoy’s Approach

The finding that most often changes the balance is limited female reproductive time—particularly advanced maternal age or diminished ovarian reserve. If waiting three to six months to treat the male factor could materially reduce the woman’s chance of pregnancy, Dr. Aksoy usually favours proceeding directly to IVF/ICSI. Severe sperm impairment, cryptozoospermia (extremely rare sperm in the ejaculate), or azoospermia requiring surgical retrieval can lower that threshold, although genetic and urological evaluation should still take place in parallel.

ICSI bypasses rather than cures the male factor. Treating a clinical varicocele or a reversible endocrine or lifestyle cause may improve semen quality and may sometimes allow natural conception or IUI, but improvement is uncertain and takes time. IVF/ICSI may offer a more direct route when time is limited, while also bringing ovarian stimulation, cost, and procedural burden for the woman. It does not remove sperm-related genetic concerns. The practical question is whether the couple can safely afford the time needed to treat the male factor first.

FAQ

Does male infertility always mean IVF is necessary?

No. Some causes are treatable without IVF, and some couples may start with less invasive options depending on age, duration of infertility, and diagnosis.

Is ICSI always better than standard IVF for male infertility?

Not always. ICSI is commonly used in significant male-factor infertility, but it is not automatically required in every case with mildly abnormal semen parameters.

Can sperm still be found if there is no sperm in the semen?

Sometimes yes. In azoospermia, sperm retrieval may still be possible depending on whether the problem is obstructive or non-obstructive.

Should genetic testing be part of the workup?

In severe oligospermia or azoospermia, genetic evaluation is often important because it can change counseling and treatment planning.

Sources

Next step

A question about your own case?

An article can set out the general picture, but not what applies to your own history. If you would like your situation looked at, you can send your questions and any previous reports to the medical team.

For privacy, please send only information needed for an initial reply. Ask the team which secure channel to use for medical reports or identity documents.

Request a medical review

Add as a Preferred Source on Google

You can add draksoyivf.com as one of your preferred health information sources on Google.

Add on Google
Dr. Senai Aksoy

Dr. Senai Aksoy studied and trained in France before returning to Turkey, where he was a founding member of the ICSI team at Sevgi Hospital, Ankara — the country's first ICSI centre (1994-95) — and a co-author on the first Turkish ICSI publications produced in collaboration with the Brussels Van Steirteghem group (Human Reproduction, 1996; PMID 8671323). He helped build the IVF programme at the American Hospital Istanbul and has been running his own fertility practice since 1998.

Verified profiles: PubMed ORCID LinkedIn

The content has been created by Dr. Senai Aksoy and medically approved.